Related Experiment Video
Updated: Feb 17, 2026
08:10
An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
Published on: January 25, 2019
8.3K
Current and Emerging Pharmacologic Therapies for Diabetic Retinopathy
Jennifer N Clements1, Julia Mesawich2, Cassandra Twisdale2
1Department of Clinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, Greenville, South Carolina, USA.
Pharmacotherapy
|February 16, 2026
Summary
Diabetic retinopathy, a leading cause of blindness, requires effective treatments. Emerging therapies and innovative delivery systems show promise for improving outcomes in managing this diabetes complication.
Area of Science:
- Ophthalmology
- Endocrinology
- Pharmacology
Background:
- Diabetic retinopathy is a major cause of adult blindness, linked to diabetes mellitus.
- Risk factors include diabetes duration, high HbA1c, hypertension, and dyslipidemia.
- Neovascularization distinguishes proliferative from non-proliferative diabetic retinopathy.
Purpose of the Study:
- To review established pharmacotherapies for diabetic retinopathy.
- To explore emerging therapies targeting inflammation, oxidative stress, and vascular stability.
- To examine innovative drug delivery systems for enhanced treatment.
Main Methods:
- Narrative review of current and investigational pharmacotherapies.
- Evaluation of novel treatment pathways and drug delivery technologies.
- Synthesis of information on agents like integrin inhibitors and gene therapies.
Main Results:
- Established treatments include laser photocoagulation, vitrectomy, and anti-VEGF agents.
- Emerging therapies target novel pathways, offering potential for improved efficacy.
- Innovative delivery systems like topical formulations and implants may enhance patient adherence.
Conclusions:
- Pharmacotherapy for diabetic retinopathy is evolving with new agents and delivery methods.
- Investigational treatments hold promise for better patient outcomes and adherence.
- Understanding these advancements is crucial for clinicians managing diabetic retinopathy.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
1.1K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
01:27Open Angle Glaucoma: Treatment
1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
01:28Drug Therapy
315
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
315
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
696
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
696
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
735
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
735
01:28Angle Closure Glaucoma: Treatment
1.3K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.3K